Literature DB >> 24021345

Multi-staged robotic stereotactic radiosurgery for large cerebral arteriovenous malformations.

Chuxiong Ding1, Timothy D Solberg, Brian Hrycushko, Paul Medin, Louis Whitworth, Robert D Timmerman.   

Abstract

PURPOSE: To investigate a multi-staged robotic stereotactic radiosurgery (SRS) delivery technique for the treatment of large cerebral arteriovenous malformations (AVMs). The treatment planning process and strategies to optimize both individual and composite dosimetry are discussed.
METHODS: Eleven patients with large (30.7 ± 19.2 cm(3)) AVMs were selected for this study. A fiducial system was designed for fusion of targets between planar angiograms and simulation CT scans. AVMs were contoured based on single contrast CT, MRI and orthogonal angiogram images. AVMs were divided into 3-8 sub-target volumes (3-7 cm(3)) for sequential treatment at 1-4 week intervals to a prescription dose of 16-20 Gy. Forward and inversely developed treatment plans were optimized for 95% coverage of the total AVM volume by dose summation from each sub-volume, while minimizing dose to surrounding tissues. Dose-volume analysis was used to evaluate the PTV coverage, dose conformality (CI), and R50 and V12 Gy parameters.
RESULTS: The treatment workflow was commissioned and able to localize within 1mm. Inverse optimization outperformed forward planning for most patients for each index considered. Dose conformality was shown comparable to staged Gamma Knife treatments.
CONCLUSION: The CyberKnife system is shown to be a practical delivery platform for multi-staged treatments of large AVMs using forward or inverse planning techniques.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Arteriovenous malformations; CyberKnife; Stereotactic radiosurgery

Mesh:

Year:  2013        PMID: 24021345     DOI: 10.1016/j.radonc.2013.07.018

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  6 in total

1.  Management of brain arteriovenous malformations.

Authors:  Sherri A Braksick; Jennifer E Fugate
Journal:  Curr Treat Options Neurol       Date:  2015-07       Impact factor: 3.598

Review 2.  Modern robot-assisted radiosurgery of cerebral angiomas-own experiences, system comparisons, and comprehensive literature overview.

Authors:  Thomas Feutren; Andres Huertas; Julia Salleron; René Anxionnat; Serge Bracard; Olivier Klein; Didier Peiffert; Valérie Bernier-Chastagner
Journal:  Neurosurg Rev       Date:  2017-11-05       Impact factor: 3.042

3.  Multistage stereotactic radiosurgery for large cerebral arteriovenous malformations using the Gamma Knife platform.

Authors:  Chuxiong Ding; Brian Hrycushko; Louis Whitworth; Xiang Li; Lucien Nedzi; Bradley Weprin; Ramzi Abdulrahman; Babu Welch; Steve B Jiang; Zabi Wardak; Robert D Timmerman
Journal:  Med Phys       Date:  2017-08-12       Impact factor: 4.071

4.  Long-term outcomes of 170 brain arteriovenous malformations treated by frameless image-guided robotic stereotactic radiosurgery: Ramathibodi hospital experience.

Authors:  Pritsana Punyawai; Nicha Radomsutthikul; Mantana Dhanachai; Chai Kobkitsuksakul; Ake Hansasuta
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

5.  Arteriovenous Malformations Treated With Frameless Robotic Radiosurgery Using Non-Invasive Angiography: Long-Term Outcomes of a Single Center Pilot Study.

Authors:  Ryan Kelly; Anthony Conte; M Nathan Nair; Jean-Marc Voyadzis; Amjad Anaizi; Sean Collins; Christopher Kalhorn; Andrew Stemer; Jeffery Mai; Rocco Armonda; Jonathan Lischalk; Frank Berkowitz; Vikram Nayar; Kevin McGrail; Brian Timothy Collins
Journal:  Front Oncol       Date:  2020-11-30       Impact factor: 6.244

6.  Image-guided robotic radiosurgery for the treatment of arteriovenous malformations.

Authors:  Franziska Loebel; Antonio Pontoriero; Anne Kluge; Giuseppe Iatì; Gueliz Acker; Markus Kufeld; Alberto Cacciola; Stefano Pergolizzi; Sergio Vinci; Sara Lillo; Ran Xu; Carmen Stromberger; Volker Budach; Peter Vajkoczy; Carolin Senger; Alfredo Conti
Journal:  PLoS One       Date:  2022-09-22       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.